ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.76
+2.41%Forward multiples
Based on analyst estimates
- P/E forward
- 15.10x
- P/E 2026E
- —
- P/E 2027E
- 10.40x
- P/E 2028E
- 22.38x
- P/S forward
- 2.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.65x
- Price / sales
- 15.82x
- Price / cash flow
- -4.47x
Enterprise value
- Enterprise value
- $98.0M
- EV / sales
- 15.82x
- EV / EBITDA
- -7.18x
- EV / EBIT
- -6.89x
- Market cap
- $98.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026